BetterInvesting Magazine Releases September Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use

Labormitarbeiter bei einer Untersuchung. (Symbolbild) © LightFieldStudios / iStock / Getty Images Plus / Getty Images http://www.gettyimages.de

PR Newswire

MADISON HEIGHTS, Mich., June 28, 2016

MADISON HEIGHTS, Mich., June 28, 2016 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Bristol-Myers Squibb Company (NYSE: BMY) as its September 2016 "Stock to Study" and MetLife, Inc. (NYSE: MET), as its September 2016 "Undervalued Stock" for investors' informational and educational use.

"The committee selected Bristol-Myers Squibb for its highly diversified product mix and growth opportunities for new products," said Adam Ritt, editor of BetterInvesting Magazine. "For the Undervalued selection, the committee believes MetLife's share price will benefit after several uncertainties facing the company are resolved."

Check BetterInvesting's September issue for more details about these selections. Go to the trial version of BetterInvesting's online tools to study the investment potential of Bristol-Myers Squibb and MetLife by viewing their fundamental data and applying judgments.

Committee members are Kenneth M. Bernard, CFA; Robert M. Bilkie, Jr., CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip S. Dano, CFA; Donald E. Danko, CFA; Maury Elvekrog, CFA; and Walter J. Kirchberger, CFA.

As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.

About BetterInvesting
BetterInvesting is a national nonprofit organization that has been empowering individual investors since 1951. Founded in Detroit, the association (formerly known as National Association of Investors Corporation) was borne out of the conviction that anyone can become a successful long-term investor by following commonsense investing practices. BetterInvesting has helped more than 5 million people become better, more informed investors by providing webinars, in-person events, easy-to-use online tools for analyzing stocks, a monthly magazine and a community of volunteers and like-minded investors. For more information about BetterInvesting, visit its website at www.betterinvesting.org or call toll free (877) 275-6242.

ARIVA.DE Börsen-Geflüster

Kurse

Bristol-Myers Squibb Corp

48,905 $

-0,17%

MetLife Inc.

72,40 $

+0,25%

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/betterinvesting-magazine-releases-september-stock-to-study-and-undervalued-stock-choices-for-investors-informational-and-educational-use-300291626.html

SOURCE BetterInvesting

Mehr Nachrichten zur Bristol-Myers Squibb Corp Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.